An observational study to assess Pharmacist Awareness and Practices on Drug Safety in North Bengaluru India
Not Applicable
- Registration Number
- CTRI/2024/02/063228
- Lead Sponsor
- Dr Aditya V
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
The community and hospital pharmacist in North Bengaluru India who give their informed consent will be included in the study.
Exclusion Criteria
Participants who do not provide their consent will be excluded from the study.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie adverse drug reactions in Bengaluru pharmacists' practice settings?
How do hospital pharmacists compare to community pharmacists in ADR reporting compliance and pharmacovigilance practices?
What biomarkers could improve patient selection for pharmacovigilance training programs in Indian healthcare settings?
Are there specific drug classes with higher underreporting rates in North Bengaluru pharmacy practice?
What management strategies do pharmacists use for common adverse drug reactions in outpatient care settings?